Advertisement

The Influence of Serotonin on Seizure Susceptibility in the Gerbil

  • K. M. A. Welch
  • Janes C. H. Chan
  • Eva Chabi
  • Tseng-Pu F. Wang

Summary

5-hydroxytryptophan (5-HTP) (50 mg/kg, I.P.) increased central serotonin (5-HT) levels and delayed the onset of seizure during reflow in gerbils subjected to transient bilateral blockade with dimethyl tryptamine (DMT) (10 mg/kg I.P.) caused early onset of seizure. Results support an influence of 5-HT on seizure threshold in the central nervous system of the gerbil.

Previous studies have shown depletion of monoamines in ischemic brain of the gerbil (9,11). When we subsequently investigated the differences in brain monoamine levels between those animals with cerebral ischemia alone and animals with ischemia that developed seizures, we found that catecholamines were only depleted in the seizure group thus raising the possibility that this was a secondary effect of seizure activity (10). Serotonin (5-HT), however, was decreased in both groups of animals. Since pharmacological depletion or elevation of brain 5-HT respectively facilitates or decreases seizure threshold in other epilepsy models (8), we have tested the hypothesis that depletion of brain 5-HT is a factor predisposing to the development of seizures in gerbils subjected to ischemia.

Keywords

Seizure Activity Seizure Onset Seizure Threshold Seizure Susceptibility Bilateral Common Carotid Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Atack, C., Lindqvist, M. (1973): Conjoint native and orthophtaldialdehyde-condensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn Schmiedebergs Arch. Pharmacol. 279: 2 67–284.Google Scholar
  2. 2.
    Chadwick, D., Jenner, P., Reynolds, E.H. (1977): Serotonin metabolism in human epilepsy: The influence of anticovulsant drugs. Ann. Neurol. 1:218–224.Google Scholar
  3. 3.
    Chen, G., Ensor, C.R., Bohner, B. (1968): Studies of drug effects on electrically induced extensor seizures and clinical implications. Arch. Int. Pharmacodyn. 172: 183–218.PubMedGoogle Scholar
  4. 4.
    Gaudet, R., Welch, K.M.A., Chabi, E., Wang, T.-P.F. (1977): Effect of transient ischemia on monoamine levels in the cerebral cortex of gerbils. J. Neurochem. (in press).Google Scholar
  5. 5.
    Kilian, M., Frey, H.H. (1973): Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology. 12: 681–692.PubMedCrossRefGoogle Scholar
  6. 6.
    Koe, K.B., Weissman, A. (1966): p-chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154: 499–516.PubMedGoogle Scholar
  7. 7.
    Loskota, W.J., Lomax, P., Rich, S.T. (1974): The gerbil as a model for the study of the epilepsies. Epilepsia. 15: 109–119.PubMedCrossRefGoogle Scholar
  8. 8.
    Maynert, E.W., Marczynski, T.J., Browning, R.A. (1975): The role of the neurotransmitters in the epilepsies. Advances in Neurology, W.J. Friedlander (ed.), Raven Press, New York (Volume 13), 79–147.Google Scholar
  9. 9.
    Welch, K.M.A., Chabi, F., Buckingham, J., Bergin, B., Achar, V.S., Meyer, J.S. (1977): Catecholamine and 5-hydroxytryptamine levels in ischemic brain. Influence of p-chlorophenylalanine. Stroke 8:341–346.Google Scholar
  10. 10.
    Welch, K.M.A., Wang, T.-P.F., Chabi, E. (1977): Ischemia-induced seizures and cortical monoamine levels. Ann. Neurol., (in press).Google Scholar
  11. 11.
    Zervas, N.T., Hori, H., Negora, M., Wurtman, R.J., Larin, F., Lavyne, M.H. (1974): Reduction in brain dopamine following experimental cerebral ischemia. Nature, 247: 283–284.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • K. M. A. Welch
    • 1
  • Janes C. H. Chan
    • 1
  • Eva Chabi
    • 1
  • Tseng-Pu F. Wang
    • 1
  1. 1.Laboratory of Clinical and Experimental Cerebral Metabolism, Baylor-Methodist Center for Cerebrovascular Research, Department of NeurologyBaylor College of MedicineHoustonUSA

Personalised recommendations